Source: United Press International
“The Food and Drug Administration has approved Moderna’s new COVID-19 vaccine, days after the federal government tightened vaccine standards for the virus. The FDA announced Friday that mNEXSPIKE can be given to adults 65 and older and those 12 to 64 with at least one underlying condition that could put them at risk of severe infection. Recipients also must have been previously vaccinated for COVID-19. The company, headquartered in Cambridge, Mass., said Saturday it expects to have the vaccine available for the 2025-2026 respiratory virus season.” (05/31/25)
https://www.upi.com/Health_News/2025/05/31/FDA-approves-Moderna-new-COVID-19-vaccine/7051748714806/